Search results for "Adjuvant"

showing 10 items of 733 documents

Preliminary communication: imiquimod in mixed capillary/lymphatic malformation.

2008

:  The present authors reported a 14-year-old white boy who visited the present authors’ dermatology department in January 2004. Physical examination revealed multiple translucent and hemorrhagic vesicles and skin-colored nodules on the chin. The lesion had grown slowly in size over the previous 7 years. The objective of this study is to estimate the exact mechanism of action of topical imiquimod on mixed capillary/lymphatic malformation. After 4 weeks of therapy the lesions were less protuberant. At the follow-up examination after a further 2 months of therapy, there was partial clinical regression of the capillary component with a return to normal skin color. One month after termination o…

Malemedicine.medical_specialtyChinAdolescentPhysical examinationImiquimodDermatologyLesionAdjuvants ImmunologicmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansLymphatic VesselsImiquimodLymphatic Abnormalitiesmedicine.diagnostic_testbusiness.industryDermatology departmentGeneral MedicineDermatologyChinSurgeryCapillariesLymphatic systemmedicine.anatomical_structureimiquimod mixed capillary/lymphatic malformationAminoquinolinesmedicine.symptomTopical imiquimodFacial NeoplasmsNormal skinbusinessHemangiomamedicine.drugDermatologic therapy
researchProduct

Unexplained neoplastic anastomotic recurrence after right hemicolectomy: a case report

2020

Abstract Background Anastomotic recurrences of the colon are postulated to arise due to inadequate margins, tumor implantation by exfoliated cells, altered biological properties of bowel anastomosis, and missed synchronous lesions. In this paper, a case of unexpected early local recurrence after surgery for colon cancer is presented. Case presentation A 68-year-old Caucasian man underwent right hemicolectomy for invasive G2 adenocarcinoma. Two months later, endoscopy revealed a wide and well-functioning anastomosis with a hyperemic, hard, and thickened mucosal area of about 2 cm in diameter. Biopsies showed the presence of an adenocarcinoma with the same grading of the previous lesion. Ten …

Malemedicine.medical_specialtyColectomiesAnastomotic recurrenceColorectal cancerColon carcinomalcsh:MedicineAnastomosis03 medical and health sciences0302 clinical medicineCase reportmedicineAdjuvant therapyHumansGrading (tumors)ColectomyAgedmedicine.diagnostic_testbusiness.industryAnastomosis Surgicallcsh:RTransverse colonRight hemicolectomyGeneral Medicinemedicine.diseaseEndoscopySurgery030220 oncology & carcinogenesisColonic NeoplasmsAdenocarcinoma030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusiness
researchProduct

Cancer in the older person.

2005

Cancer in the older person is an increasingly common problem, due to the progressive prolongation of the life-expectancy of the Western population. This article reviews the mechanisms associating aging and cancer, age-related changes in cancer biology, assessment of the older person to estimate life-expectancy, treatment tolerance, and medical and social conditions that may interfere with cancer treatment, effectiveness of cancer prevention and cancer treatment in older individuals. A comprehensive geriatric assessment (CGA) is commonly used to predict life-expectancy and functional reserve and to unearth conditions that may jeopardize cancer prevention and treatment. In the interest of cos…

Malemedicine.medical_specialtyColorectal cancerPopulationPRIMARY-CARE PATIENTSPainDiseaseProstate cancerNeoplasmsMedicineHumansPain ManagementRadiology Nuclear Medicine and imagingNON-HODGKINS-LYMPHOMAIntensive care medicineeducationELDERLY-PATIENTSGeriatric AssessmentSURGICAL ADJUVANT BREASTPreventive healthcareAgededucation.field_of_studyCancer preventionbusiness.industryCOMPREHENSIVE GERIATRIC ASSESSMENTCancerGeneral MedicineRANDOMIZED CONTROLLED-TRIALCOLONY-STIMULATING FACTORmedicine.diseasePROSTATE-CANCERClinical trialOncologyCOOPERATIVE-ONCOLOGY-GROUPPhysical therapyDIFFUSE HISTIOCYTIC LYMPHOMAFemalebusinessCancer treatment reviews
researchProduct

Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.

2015

The implementation of preoperative chemoradiation combined with total mesorectal excision has reduced local recurrence rates in rectal cancer. However, the use of both types of treatment in upper rectal cancer is controversial.The purpose of this work was to assess oncological results after radical resection of upper rectal cancers compared with sigmoid, middle, and lower rectal cancers and to determine risk factors for local recurrence in upper rectal cancer.This was a retrospective analysis of prospectively collected data.This study was conducted in a tertiary care referral hospital in Valencia, Spain.Analysis included 1145 patients who underwent colorectal resection with primary curative…

Malemedicine.medical_specialtyColorectal cancerUnnecessary ProceduresPreoperative careDisease-Free SurvivalRisk FactorsPreoperative CareMedicineHumansSurvival rateAgedNeoplasm StagingRetrospective StudiesPreoperative chemoradiotherapybusiness.industryRectal NeoplasmsGastroenterologyFollow up studiesRetrospective cohort studyGeneral MedicineChemoradiotherapy Adjuvantmedicine.diseasePrognosisTotal mesorectal excisionMagnetic Resonance ImagingSurvival RateSigmoid NeoplasmsTreatment OutcomeFemaleRadiologyNeoplasm Recurrence LocalbusinessChemoradiotherapyFollow-Up StudiesDiseases of the colon and rectum
researchProduct

Influence of non-clinical factors on restorative rectal cancer surgery: An analysis of four specialized population-based digestive cancer registries …

2022

Abstract Background This study aims to measure the association between deprivation, health care accessibility and health care system with the likelihood of receiving non-restorative rectal cancer surgery (NRRCS). Methods All adult patients who had rectal resection for invasive adenocarcinoma diagnosed between 2007 and 2016 in four French specialised cancer registries were included. A multilevel logistic regression with random effect was used to assess the link between patient and health care structure characteristics on the probability of NRRCS. Results 2997 patients underwent rectal cancer resection in 68 health care structures: 708 (23.63%) had NRRCS. The likelihood of receiving NRCCS was…

Malemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentAdenocarcinomaHealth Services AccessibilityInternal medicineHealth careMedicineHumansRegistriesStage (cooking)Neoadjuvant therapyAgedAged 80 and overLikelihood FunctionsProctectomyHepatologybusiness.industryRectal NeoplasmsProctocolectomy RestorativeGastroenterologyCancerMiddle Agedmedicine.diseaseLogistic ModelsNon clinicalRectal cancer surgeryMultilevel AnalysisAdenocarcinomaFemaleFranceSocial DeprivationbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Prognostic Heterogeneity of Endosonographic T3 Rectal Cancer

2009

PURPOSE: This study aimed to assess the prognostic implications of uT3 rectal carcinomas according to the tumor thickness and to analyze the correlation between this ultrasound-based parameter and other prognostic factors. METHODS: Seventy-four patients with uT3(pM0) rectal tumors underwent primary surgery from 1996 to 2003. Preoperative endorectal ultrasound was used to assess uN stage, maximum tumor perimeter, and maximum tumor thickness. An ultrasound maximum tumor thickness cutoff point for local recurrence subdividing T3 tumors into uT3a and uT3b was established. RESULTS: Median follow-up was 41 months (range, 24-59). The 5-year actuarial local and overall recurrence rates were 9.82 pe…

Malemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentKaplan-Meier EstimateEndosonographyPerimeterHumansMedicineNeoplasm InvasivenessStage (cooking)Neoadjuvant therapyAgedRectal Neoplasmsbusiness.industryHazard ratioUltrasoundGastroenterologyCancerGeneral MedicineMiddle AgedPrognosismedicine.diseaseConfidence intervalFemaleRadiologyNeoplasm Recurrence LocalbusinessDiseases of the Colon & Rectum
researchProduct

Surgical treatment of pharyngostomes in irradiated patients. Our experience with musculocutaneous pectoralis major flap and hyperbaric oxygen therapy

2005

Surgical treatment of pharyngostomes in irradiated patients. Our experience with musculocutaneous pectoralis major flap and hyperbaric oxygen therapy. Cordova A, Corradino B, Pirrello R, Di Lorenzo S, Dispenza C, Moschella F. Source Dipratimento di Discipline Chirurgiche ed Oncologiche, Divisione di Chirurgia Plastica e Ricostruttiva, Facolta di Medicina, Universita di Palermo, Palermo, Italy. chirplas@unipa.it Abstract CONCLUSION: Our experience confirms that pectoralis major flap is the first-choice technique for repairing recurrent hypopharyngeal fistulae in previously irradiated patients in whom microsurgical techniques are not indicated, and that hyperbaric oxygen therapy helps to solv…

Malemedicine.medical_specialtyCutaneous FistulaFistulamedicine.medical_treatmentLaryngectomyHyperbaric oxygen therapy hypopharyngeal fistula pectoralis major flap pharyngolaryngeal carcinoma pharyngolaryngeal reconstruction pharyngostomeSurgical FlapsPectoralis MusclesPostoperative ComplicationsCarcinomamedicineHumansSurgical FlapsPectoralis MuscleLaryngeal NeoplasmsAgedAged 80 and overHyperbaric Oxygenationbusiness.industryPectoralis major musclePharyngeal NeoplasmsPharyngeal DiseasesGeneral MedicineMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurgeryLaryngectomyTreatment OutcomePharyngeal NeoplasmOtorhinolaryngologyFemaleRadiotherapy AdjuvantComplicationbusiness
researchProduct

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia

2011

We conducted an international phase 2 trial to evaluate 2 dose levels of ofatumumab, a human CD20 mAb, combined with fludarabine and cyclophosphamide (O-FC) as frontline therapy for chronic lymphocytic leukemia (CLL). Patients with active CLL were randomized to ofatumumab 500 mg (n = 31) or 1000 mg (n = 30) day 1, with fludarabine 25 mg/m2 and cyclophosphamide 250 mg/m2 days 2-4, course 1; days 1-3, courses 2-6; every 4 weeks for 6 courses. The first ofatumumab dose was 300 mg for both cohorts. The median age was 56 years; 13% of patients had a 17p deletion; 64% had β2-microglobulin > 3.5 mg/L. Based on the 1996 National Cancer Institute Working Group (NCI-WG) guidelines, the complete respo…

Malemedicine.medical_specialtyCyclophosphamideClinical Trials and ObservationsChronic lymphocytic leukemiaImmunologyMedizinNeutropeniaOfatumumabAntibodies Monoclonal HumanizedBiochemistryGastroenterologychemistry.chemical_compoundChemoimmunotherapyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansCyclophosphamideCD20Chlorambucilbiologybusiness.industryAntibodies MonoclonalCell BiologyHematologyMiddle Agedmedicine.diseaseCombined Modality TherapyLeukemia Lymphocytic Chronic B-CellNeoadjuvant TherapySurgeryFludarabineTreatment Outcomechemistrybiology.proteinFemaleImmunotherapybusinessVidarabinemedicine.drug
researchProduct

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral…

2020

Objectives: The aim of this multicenter study was to investigate the prognostic role of type 2 diabetes mellitus (T2DM) comorbidity in a large multi-institutional cohort of patients with primary T1HG/G3 non–muscle-invasive bladder cancer (NMIBC) treated with transurethral resection of the bladder (TURB). Materials and methods: A total of 1,172 patients with primary T1 HG/G3 who had NMIBC on re-TURB and who received adjuvant intravesical bacillus Calmette-Guérin therapy with maintenance were included. Endpoints were recurrence-free survival and progression-free survival. Results: A total of 231 (19.7%) of patients had T2DM prior to TURB. Five-year recurrence-free survival estimates were 12.5…

Malemedicine.medical_specialtyDiabetes mellituUrologymedicine.medical_treatment030232 urology & nephrologyUrologyCystectomyResection03 medical and health sciences0302 clinical medicineDiabetes mellitusHigh gradeAdjuvants ImmunologicUrethraRecurrenceDiabetes mellitusmedicineHumansIn patientNeoplasm InvasivenessAgedNeoplasm StagingRetrospective StudiesBladder cancerProgressionbusiness.industryHigh riskBladder cancerType 2 Diabetes MellitusMiddle Agedmedicine.diseasePrognosisComorbidityProgression-Free Survival3. Good healthBladder cancer; Diabetes mellitus; High grade; High risk; Progression; RecurrenceSettore MED/24OncologyDiabetes Mellitus Type 2Urinary Bladder NeoplasmsChemotherapy Adjuvant030220 oncology & carcinogenesisCohortBCG VaccineFemaleNeoplasm GradingbusinessAdjuvantUrologic oncology
researchProduct

Recurrence of esophageal cancer after R0 surgery: risk factors and evolution

2013

Introduction despite advances in surgical and adjuvant therapy, recurrence in esophageal cancer submitted to R0 surgery remains high. The aim is to define risk factors and recurrence patterns. Additionally, to show the management carried out and the outcome of patients showing recurrence. Material and methods observational and prospective study that included 61 patients. Neoadjuvancy therapy was indicated on T3, T4 and N+ tumors and every lymph node dissection was performed in two fields. Recurrence is defined at distance, regional or local, when, recurrence is detected after six months. According to clinical features and the recurrences, a palliative, chemotherapeutic or surgical managemen…

Malemedicine.medical_specialtyEsophageal NeoplasmsEsophageal cancerRecurrenciaCurative esophagectomyPrognostic factorsRecurrenceRisk FactorsAdjuvant therapymedicineHumansProspective StudiesStage (cooking)Risk factorlcsh:RC799-869Prospective cohort studyLymph nodeCáncer de esófagobusiness.industryEsofaguectomía curativaGastroenterologyGeneral MedicineMiddle AgedEsophageal cancermedicine.diseaseSurgeryDissectionTreatment Outcomemedicine.anatomical_structureFemalelcsh:Diseases of the digestive system. GastroenterologyLymphNeoplasm Recurrence LocalbusinessFactores pronósticoRevista Espanola de Enfermedades Digestivas
researchProduct